CPUHU - CPUHU STOCK NEWS

Allurion Technologies and Compute Health Acquisition Corp. have received stockholder approval for their business combination. Approximately 99.8% of the votes cast were in favor of the combination, representing approximately 87.7% of Compute Health's outstanding common stock. The closing of the business combination is expected to occur on or about August 1, 2023, and the combined company will operate as Allurion Technologies, Inc. and be listed on the New York Stock Exchange.

Compute Health Acquisition Corp. announced that the proposal to amend the warrant agreement governing its outstanding warrants was approved by its warrant holders. The Business Combination between Allurion Technologies, Inc. and Compute Health is anticipated to close shortly after the approval of the relevant proposals at the Special Meeting.

Allurion Technologies announces the appointment of Douglas Hudson to the Board of Directors and Tomer Stavitsky as VP of Corporate Development. Hudson brings deep experience in healthcare consumerization, while Stavitsky has expertise in healthcare M&A and partnerships. Allurion is going public through a business combination with Compute Health.

Stockholders of Record as of July 3, 2023 are Eligible to Vote at Special Meeting on July 28, 2023

Allurion Technologies and Compute Health Acquisition Corp. have announced updated terms to the warrant agreement that governs the outstanding warrants of Compute Health. The terms include changes to the exercise price, the number of shares exercisable, and the expiration date of the warrants.

Allurion Technologies and Compute Health Acquisition Corp (NYSE: CPUH) have entered into a business combination agreement, positioning Allurion to become publicly listed as Allurion Technologies, Inc. This innovative company is focused on obesity treatment, featuring the Allurion Gastric Balloon, a swallowable gastric balloon that allows for procedure-less weight loss. Since its inception, Allurion has treated over 100,000 patients worldwide, achieving an average weight loss of 30 pounds. Revenue has surged from $20 million in 2020 to $64 million in 2022. The transaction includes significant investments from RTW Investments and other notable figures.

Compute Health Acquisition Corp. (NYSE: CPUH.U) announced that starting March 29, 2021, holders of its 86,250,000 IPO units may separately trade shares of Class A common stock and redeemable warrants. The units will continue to trade under the symbol CPUH.U, while separated shares and warrants will trade under CPUH and CPUH WS. The Company aims to pursue merger opportunities in the healthcare sector focusing on technology-driven solutions. Goldman Sachs served as the sole book-running manager for the IPO.